Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
Ellen RomichDidem SayginDana DiRenzoChristopher A MecoliIngrid de GrootKarin LodinMalin RegardtCatherine SarverJu Yeon KimJin Kyun ParkKelly BeerMerrilee NeedhamHelene AlexandersonLisa Christopher-StineMarianne de VisserJoost Raaphorstnull nullPublished in: Seminars in arthritis and rheumatism (2024)
PROMIS Short Form v1.0-Pain Interference 6a, PROMIS Short Form v1.0-Fatigue 7a, and PROMIS Short Form v2.0-Physical Function 8b measures demonstrate strong construct validity when compared to core disease activity measures in IIM, with consistent results across IIM subtypes. These findings support the use of these selected PROMIS measures to assess core domains of interest for measuring life impact in IIMs.
Keyphrases
- patient reported outcomes
- disease activity
- chronic pain
- rheumatoid arthritis
- systemic lupus erythematosus
- pain management
- rheumatoid arthritis patients
- neuropathic pain
- ankylosing spondylitis
- sleep quality
- oxidative stress
- juvenile idiopathic arthritis
- interstitial lung disease
- spinal cord injury
- spinal cord
- systemic sclerosis